We could not discard that tau phosphorylation by other kinases that are implicated in AD, such as CDK5 (Liu et al., 2016), AMPK (Tu et al., 2014), MAPKs (Zu et al. 2001), could also affect AChE expression, like GSK3β. Here, MAPT is linked to Alzheimer disease.